Thiamin in Clinical Practice

Journal of Parenteral and Enteral Nutrition

Volumn 39, Issue 5, 2015, Pages 503-520

  Frank, Laura L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

adult; life cycle; nutrition; nutrition assessment; research and diseases; vitamins

Indexed keywords

THIAMINE; TRANSKETOLASE; VITAMIN B COMPLEX;

ALCOHOLISM; BARIATRIC SURGERY; BRAIN METABOLISM; CLINICAL PRACTICE; CRITICAL ILLNESS; DIETARY REFERENCE INTAKE; DIGESTION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; EVIDENCE BASED PRACTICE; HEART FAILURE; HUMAN; KIDNEY FAILURE; NUTRIENT; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; REFEEDING SYNDROME; REVIEW; SUPPLEMENTATION; THIAMINE DEFICIENCY; ADULT; CHILD; CLINICAL PROTOCOL; FEMALE; MALE; METABOLISM; PREGNANCY; RISK FACTOR;

ADULT; CHILD; CLINICAL PROTOCOLS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; NUTRITIONAL SUPPORT; PREGNANCY; RISK FACTORS; THIAMINE; THIAMINE DEFICIENCY; VITAMIN B COMPLEX;

EID: 84932184363     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114565245     Document Type: Review

References (141)

1. Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: Food and Nutrition Board, National Academy Press ; 1998 :
2. Combs GF The Vitamins: Fundamental Aspects in Nutrition and Health. San Diego, CA: Academic Press ; 2012 :
3. Gropper SS, Smith JL, Groff JL Advanced Nutrition and Human Metabolism. 5 th ed.Belmont, CA: Wadsworth; 2009. Belmont, CA: Wadsworth ; 2009 :
4. Rindi G. Thiamin absorption by small intestine. Acta Vitaminol Enzymol. 1984 ; 6: 47-55
5. Said HM, Ortiz A, Subramanian VS, Neufeld EJ, Moyer MP, Dudeja PK. Mechanism of thiamine uptake by human colonocytes: studies with cultured colonic epithelial cell line NCM460. Am J Physiol Gastrointest Liver Physiol. 2001 ; 281: G144 - G150
6. Clements RH, Katasani VG, Palepu R, et al. Incidence of vitamin deficiency after laparoscopic Roux-en Y gastric bypass in a university hospital setting. Am Surg. 2006 ; 72: 1196-1202
7. Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol. 2012 ; 12: 1-10
8. Hoyumpa AM Jr, Strickland R, Sheehan JJ, Yarborough G, Nichols S. Dual system of intestinal thiamine transport in humans. J Lab Clin Med. 1982 ; 99: 701-708
9. Dudeja P, Tyagi S, Gill R, Said H. Evidence for a carrier-mediated mechanism for thiamine transport to human jejuna basolateral membrane vesicles. Dig Dis Sci. 2003 ; 48: 109-115
10. Ganapathy V, Smith S, Prasad P. SLC19: the folate/thiamin transporter family. Pflugers Arch. 2004 ; 447: 641-646
11. Subramanian V, Marchant J, Parker I, Said H. Cell biology of the human thiamine transporter-1 (hThTR1): intracellular trafficking and membrane targeting mechanisms. J Biol Chem. 2003 ; 278: 3976-3984
12. Thomson AD, Baker H, Leevy CM. Patterns of 35S-thiamin hydrochloride absorption in malnourished, alcoholic patient. J Lab Clin Med. 1970 ; 76: 34-45
13. Thomson AD, Jeyasingham MD, Pratt OE, et al. Nutrition and alcoholic encephalopathies. Acta Med Scan Suppl. 1987 ; 717: 55-65
14. Thomson AD. Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl. 2000; 35(suppl 1):2-7.
15. Gangolf M, Czerniecki J, Radermecker M, et al. Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells. PLoS One. 2010 ; 5 (10). e13616
16. Talwar D, Davidson H, Cooney J, St. JO'Reilly D. Vitamin B1 status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay. Clin Chem. 2000 ; 46: 704-710
17. Bettendorff L, Wins P. Biological functions of thiamine derivatives: focus on non-coenzyme roles. OA Biochem. 2013 ; 1 (1). 10
18. Donnino MW, Vega J, Miller J, Walsh M. Myths and misconceptions of Wernicke's encephalopathy: what every emergency physician should know. Ann Emerg Med. 2007 ; 50: 715-721
19. Hazell AS, Butterworth RF. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity, and inflammation. Alcohol Alcohol. 2009:44(2):141-147.
20. Centers for Disease Control and Prevention. Lactic acidosis traced to thiamine deficiency related to nationwide shortage of multivitamins for total parenteral nutrition - United States, 1997. Morbid Mortal Wkly Rep MMWR. 1997 ; 46 (23). 523-528
21. Thomson AD, Cook CCH, Touquet R, Henry JA. The Royal College of Physicians Report on Alcohol: guidelines for managing Wernicke's encephalopathy in the accident and emergency department. Alcohol Alcohol. 2002 ; 37 (6). 513-521
22. Strauss KA, Puffenberger EG, Morton DH. Maple syrup urine disease. GeneReviews®. Seattle, WA: University of Washington. Initial posting: January 30, 2006; last update: May 9, 2013. Accessed August 23, 2014.
23. Kaneda K, Kikuchi M, Kashii S, et al. Effects of B vitamins on glutamate-induced neurotoxicity in retinal cultures. Eur J Pharmacol. 1997 ; 322 (2-3). 259-264
24. Geng MY, Saito H, Katsuki H. The effects of thiamine and oxythiamine on the survival of cultured brain neurons. Jpn J Pharmacol. 1995 ; 68 (3). 349-352
25. Eder L, Hirt L, Dunant Y. Possible involvement of thiamine in acetylcholine release. Nature. 1976 ; 254 (5582). 186-188
26. Romanenko AV, Gnatenko VM, Vladimirova IA. Effect of thiamine on neuromuscular transmission of smooth muscles. Neurophysiology. 1994 ; 26 (6). 370-376
27. Yamashita H, Zhang YX, Nakamura S. The effects of thiamin and its phosphate esters on dopamine release in the rat striatum. Neurosci Lett. 1993 ; 158 (2). 229-231
28. Biasioli S, D'Andrea G, Chiaramonte S, et al. The role of neurotransmitters in the genesis of uremic encephalopathy. Int J Artif Organs. 1984 ; 7 (2). 101-106
29. Harper CG, Butterworth RF Nutritional and Metabolic Disorders Greenfield's Neuropathology. Graham DI Lantose PL, eds. London, UK: Arnold, 1997:601-655.
30. Gibson GE, Ksiezak-Reding H, Sheu KFR, et al. Correlation of enzymatic, metabolic, and behavioural deficits in thiamine deficiency and its reversal. Neurochem Res. 1984 ; 9: 803-814
31. Butterworth RF, Giguere JF, Besnard AM. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 2. α-ketoglutarate. Neurochem Res. 1986 ; 11: 567-577
32. Butterworth RF. Pathophysiologic mechanisms responsible for the reversible (thiamine-responsive) and irreversible (thiamine non-responsive) neurologic symptoms of Wernicke's encephalopathy. Drug Alcohol Rev. 1993 ; 12: 315-322
33. Langlais PJ, Anderson G, Guo SX, et al. Increased cerebral free radical production during thiamine deficiency. Metab Brain Dis. 1997 ; 12: 137-143
34. Yang G, Meng Y, Li W, et al. Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol. 2011 ; 21 (3). 279-297
35. Gibson GE, Zhang H. Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem Int. 2002 ; 40: 493-504
36. Todd KG, Butterworth RF. Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia. 1999 ; 25: 190-198
37. Gibson GE, Park LC, Zhang H, Sorbi S, Calingasan NY. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. Ann N Y Acad Sci. 1999 ; 893: 79-94
38. Cao W, Carney JM, Duchon A, Floyd RA, Chevion M. Oxygen free radical involvement in ischemia and reperfusion injury to the brain. Neurosci Lett. 1988 ; 88: 235-238
39. Kruse M, Navarro D, Desjardins P, Butterworth RF. Increased brain endothelial nitric oxide synthase expression in thiamine deficiency: relationship to selective vulnerability. Neurochem Int. 2004 ; 45 (1). 49-56
40. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994 ; 298 (pt 2). 249-258
41. Förstermann U, Schmidt HH, Pollock JS, et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol. 1991 ; 42 (10). 1849-1857
42. Guix FX, Uribesalgo I, Coma M, Muñoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005 ; 76 (2). 126-152
43. Calingasan NY, Park LC, Calo LL, Trifiletti RR, Gandy SE, Gibson GE. Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol. 1998 ; 153 (2). 599-610
44. Brown GC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome C oxidase. Biochim Biophys Acta. 2001 ; 1504: 46-57
45. Bergui M, Bradac GB, Zhong JJ, et al. Diffusion-weighted MR in versible Wernicke encephalopathy. Neuroradiology. 2001 ; 43: 969-972
46. Pellerin L, Bouzier-Sore AK, Aubert A, et al. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia. 2007 ; 55: 1251-1262
47. Kimelberg HK, Goderie SK, Higman S, et al. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci. 1990 ; 10: 1583-1591
48. Kimelberg HK, Rutledge E, Goderie S, et al. Astrocyte swelling due to hypotonic or high K+ medium cause inhibition of glutamate and aspartate uptake and increases their release. J Cereb Blood Flow Metab. 1995 ; 15: 409-416
49. Rieck J, Halkin H, Almog S, et al. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. J Lab Clin Med. 1999 ; 134: 238-243
50. Lubetsky A, Winaver J, Seligmann H, et al. Urinary thiamine excretion in the rat: effects of furosemide, other diuretics, and volume load. J Lab Clin Med. 1999 ; 134: 232-237
51. Council on Scientific Affairs, American Medical Association. Vitamin preparations as dietary supplements and as therapeutic agents. JAMA. 1987 ; 257: 1929-1936
52. Wrenn KD, Murphy F, Slovis CM. A toxicity study of parenteral thiamine hydrochloride. Ann Emerg Med. 1989 ; 18: 867-870
53. Wrenn KD, Slovis CM. Is Intravenous thiamin safe?. Am J Am Med. 1992 ; 10: 165
54. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012 ; 8: 544-556
55. Donnino MW, Carney E, Cocchi MN, et al. Thiamin deficiency in critically ill patients with sepsis. J Crit Care. 2010 ; 25: 576-581
56. Manzanares W, Hardy G. Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care. 2011 ; 14: 610-617
57. Donnino MW, Cocchi MN, Smithline H, Carney E, Chou PP, Salciccioli J. Coronary artery bypass graft surgery depletes plasma thiamine levels. Nutrition. 2010 ; 26: 133-136
58. Frank T, Czeche K, Bitsch R, Stein G. Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation. Int J Vitam Nutr Res. 2000 ; 70: 159-166
59. Dancy M, Evans G, Gaitonde MK, Maxwell JD. Blood thiamin and thiamine phosphate ester concentrations in alcoholic patient and non-alcoholic liver disease. Br Med J. 1984 ; 289: 79-82
60. Bates CJ. Vitamin analysis. Ann Clin Biochem. 1997 ; 34: 599-626
61. Puxty JAH, Haskew AE, Ratcliffe JG, McMurray J. Changes in erythrocyte transketolase activity and the thiamin pyrophosphate effect during storage of blood. Ann Clin Biochem. 1985 ; 22: 423-427
62. Wood B, Breen K, Pennington D. Thiamine status in alcoholism. Aust N Z J Med. 1997 ; 7: 475-484
63. Kaczmarek MJ, Nixon PF. Variants of transketolase from human erythrocytes. Clin Chim Acta. 1983 ; 130: 249-256
64. Kjosen B, Seim SH. The transketolase assay of thiamine in some diseases. Am J Clin Nutr. 1977 ; 30 (10). 1591-1596
65. Camilo ME, Morgan MY, Sherlock S. Erythrocyte transketolase activity in alcoholic liver disease. Scand J Gastroenterol. 1981 ; 16: 273-279
66. Anderson SH, Nicol A. A fluorometric method for measurement of erythrocyte transketolase activity. Ann Clin Biochem. 1986 ; 23: 180-189
67. Warnock LG, Prudhomme CR, Wagner C. The determination of thiamin pyrophosphate in blood and other tissues and its correlation with erythrocyte transketolase activity. J Nutr. 1978 ; 108: 421-427
68. Baines M, Davies G. The evaluation of erythrocyte thiamin diphosphate as an indicator of thiamin status in man and its comparison with erythrocyte transketolase activity measurements. Ann Clin Biochem. 1988 ; 25: 698-705
69. Bayliss R, Brookes R, McCulloch J, et al. Urinary thiamine excretion after oral physiologic doses of the vitamin. Intern J Vitam Nutr Res. 1984 ; 54: 161-164
70. Nakasaki H, Ohta M, Soeda J, et al. Clinical and biochemical aspects of thiamine treatment for metabolic acidosis during total parenteral nutrition. Nutrition. 1997 ; 13 (2). 110-117
71. McDowell JE, Leblanc HJ. Computed tomographic findings in Wernicke-Korsakoff syndrome. Arch Neurol. 1984 ; 41: 453-454
72. Manzo G, De Gennaro A, Cozzolino A, Serino A, Fenza G, Manto A. MR imaging findings in alcoholic and nonalcoholic acute Wernicke's encephalopathy: a review. Biomed Res Int. 2014 ; 2014: 503-596
73. Shah HN, Bal BS, Finelli FC, Koch TR. Constipation in patients with thiamine deficiency after Roux-en-Y gastric bypass. Digestion. 2013 ; 88: 119-124
74. Lakhani SV, Shah HN, Alexander K, Finelle FC, Kirkpatrick JR, Koch TR. Small intestinal bacterial overgrowth and thiamin deficiency after Roux-en Y gastric bypass surgery in obese patients. Nutr Res. 2008 ; 28: 293-298
75. Cook CCH, Hallwood PM, Thomson AD. B-vitamin deficiency and neuro-psychiatric syndrome in alcohol misuse. Alcohol Alcohol. 1998 ; 33: 317-336
76. Wernicke C Lehrbuch der Gehirnkrankheiten fur Aerzte und Studirende. Vol 2. Kassel, Germany: Theodor Fischer; 1881:229-42.
77. Royal College of Physicians. Report of a Working Party: Alcohol - Can the NHS Afford It? Recommendations for a Coherent Alcohol Strategy for Hospitals. London, UK: Royal College of Physicians ; 2001 :
78. Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010 ; 17 (12). 1408-1418
79. White JV, Guenter P, Jensen G, Malone A, Schofield M. Academy Malnutrition Work Group, A.S.P.E.N. Malnutrition Task Force and the A.S.P.E.N.Board of Directors. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr. 2012 ; 36: 275-283
80. Thomson AD, Marshall EJ, Guerrini I. Biomarkers for detecting thiamine-deficiency-improving confidence and taking a comprehensive history are also important. Alcohol Alcohol. 2010 ; 45: 213
81. Frank LL Nutritional Management of the Bariatric Surgery Patient. Clarksville, MD: Wolf Rinke Associates ; 2012.
82. Sullivan JT, Skykora K, Schneiderman J, Naranjo A, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989 ; 84 (11). 1353-1357
83. Pitel AL, Zahr NM, Jackson K, et al. Signs of preclinical Wernicke's encephalopathy and thiamine levels as predictors of neuropsychological defects in alcoholism without Korsakoff's syndrome. Neuropsychopharmacol. 2011 ; 36: 580-588
84. Paparrigopoulos T, Tzavellas E, Karaiskos D, Kouzoupis A, Liappas I. Complete recovery from undertreated Wernicke-Korsakoff syndrome following aggressive thiamin treatment. In Vivo. 2010 ; 24: 231-233
85. Ambrose ML, Bowden SC, Whehan G. Thiamine treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res. 2001 ; 25: 112-116
86. Gollobin C, Marcus W. Bariatric beriberi. Obes Surg. 2002 ; 12: 309-311
87. Stroh C, Meyer F, Manger T. Beriberi, a severe complication after metabolic surgery: review of the literature. Obes Facts. 2014 ; 7 (4). 246-252
88. Aasheim ET, Bjorkman S, Sovik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009 ; 90: 15-22
89. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJB. A controlled study of peripheral neuropathy after bariatric surgery. Neurology. 2004 ; 63: 1462-1470
90. Kumar N. Neurologic complications of bariatric surgery. Continuum (Minneap Minn). 2014 ; 20: 580-597
91. Landais A. Neurological complications of bariatric surgery. Obes Surg. 2014 ; 24 (10). 1800-1807
92. Fragoso YD, Alves-Leon SV, Anacleto Ade C, et al. Neurological complications following bariatric surgery. Arq Neuropsiquiatr. 2012 ; 70 (9). 700-703
93. Koffman BM, Greenfield LJ, Ali II, Pirzada NA. Neurologic complications after surgery for obesity. Muscle Nerve. 2006 ; 33 (2). 166-176
94. Chaves L, Faintuch J, Kahwage S, Alencar F. A Cluster of polyneuropathy and Wernicke-Korsakoff syndrome in a bariatric unit. Obes Surg. 2002 ; 12: 328-334
95. Singh S, Kumar A. Wernicke encephalopathy after obesity surgery: a systematic review. Neurology. 2007 ; 68: 807-811
96. Aasheim ET. Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg. 2008 ; 248 (5). 714-720
97. Milone M, Di Minno MN, Lupoli R, et al. Wernicke encephalopathy in subjects undergoing restrictive weight loss surgery: a systematic review of literature data. Eur Eat Disord Rev. 2014 ; 22 (4). 222-229
98. Aills L, Blankenship J, Buffington C, Furtado M, Parrot J. Bariatric nutrition: suggestions for the surgical weight loss patient. Surg Obes Relat Dis. 2008 ; 4 ( 45 ):S-73-108
99. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient - 2013 update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013 ; 9: 159-191
100. Thomson AD, Marshall EJ. The treatment of patients at risk of developing Wernicke's encephalopathy in the community. Alcohol Alcohol. 2006; 41:159-167
101. U.S. Department of Health and Human Services, Food and Drug Administration. Parenteral multivitamin products: drugs for human use; drug efficacy study implementation; amendment. Fed Reg. 2000 ; 65: 21200-21201
102. DiNicolantonio JJ, Lavie CJ, Niazi AK, O'Keefe JH, Hu T. Effects of thiamine on cardiac function in patients with systolic heart failure: systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials. Ochsner J. 2013 ; 13 (4). 495-499
103. Zenuk C, Healey J, Donnelly J, Vaillancourt R, Almalki Y, Smith S. Thiamine deficiency in congestive heart failure patients receiving long-term furosemide therapy. Can J Clin Pharmacol. 2003 ; 10 (4). 184-188
104. Hanninen SA, Darling PB, Sole MJ, Barr A, Keith ME. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol. 2006 ;17; 47 (2). 354-361
105. Seligmann H, Halkin H, Rauchfleisch S, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med. 1991 ; 91 (2). 151-155
106. Ahmed M, Azizi-Namini P, Yan AT, Keith M. Thiamin deficiency and heart failure: the current knowledge and gaps in literature [published ahead of print May 9, 2014]. Heart Fail Rev.
107. Shimon I, Almog S, Vered Z, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med. 1995 ; 98 (5). 485-490
108. Schoenenberger AW, Schoenenberger-Berzins R, der Maur CA, Suter PM, Vergopoulos A, Erne P. Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol. 2012 ; 101 (3). 159-164
109. Freye E, Hartung E. The potential use of thiamine in patients with cardiac insufficiency. Acta Vitaminol Enzymol. 1982 ; 4 (4). 285-290
110. Vanek VW, Borum P, Buchman A, et al. Parenteral Multi-vitamin and Multi-trace Element Working Group; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. ASPEN position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract. 2012 ; 27: 440-491
111. Nishiwaki S, Iwashita M, Goto N, et al. Predominant copper deficiency during prolonged enteral nutrition through a jejunostomy tube compared to that through a gastrostomy tube. Clin Nutr. 2011 ; 30: 585-589
112. Ferrie S. Case report of acute thiamine deficiency occurring as a complication of vitamin-free parenteral nutrition. Nutr Clin Pract. 2012 ; 27: 65-68
113. Nakasaki H, Ohta M, Soeda J, et al. Clinical and biochemical aspects of thiamine treatment for metabolic acidosis during total parenteral nutrition. Nutrition. 1997 ; 13 (2). 110-117
114. Kitamura K, Yamaguchi T, Tanaka H, Hashimoto S, Yang M, Takahashi T. TPN-induced fulminant beriberi: a report on our experience and a review of the literature. Surg Today. 1996 ; 26 (10). 769-776
115. Schiano TD, Klang MG, Quesada E, Scott F, Tao Y, Shike M. Thiamine status in patients receiving long-term home parenteral nutrition. Am J Gastroenterol. 1996 ; 91 (12). 2555-2559
116. Solomon SM, Kirby DF. The refeeding syndrome: a review. JPEN J Parenter Enteral Nutr. 1990 ; 14: 90-97
117. Walmsley RS. Refeeding syndrome: screening, incidence, and treatment during parenteral nutrition. J Gastroenterol Hepatol. 2013; 28 (suppl 4): 113-117
118. Mehler PS, Winkelman AB, Andersen DM, Gaudiani JL. Nutritional rehabilitation: practical guidelines for refeeding the anorectic patient. J Nutr Metab. 2010 ;pii: 625782
119. Mehenna HM, Moledina J, Travis J. Refeeding syndrome: what is it, and how to prevent and treat it. Br Med J. 2008 ; 336: 1495-1498
120. Perrault MM, Ostrop NJ, Tierney MG. Efficacy and safety of intravenous phosphate replacement in critically ill patients. Ann Pharmacother. 1997 ; 31: 683-688
121. National Institute for Health and Clinical Excellence (NICE). Nutrition Support in Adults. Clinical Guideline CG32. 2006. www.nice.org.uk/page.aspx?o=cg032. Accessed October 8, 2014.
122. Maiorana A, Vergine G, Coletti V, et al. Acute thiamine deficiency and refeeding syndrome: similar findings but different pathogenesis. Nutrition. 2014 ; 30 (7-8). 948-952
123. Sanz París A, Albero Gamoa R, Acha Pérez FJ, Playán Usón J, Casamayor Peris L, Celaya Pérez S. Thiamine deficiency associated with parenteral nutrition: apropos of a new case. Nutr Hosp. 1994 ; 9 (2). 110-113
124. Seligmann H, Levi R, Konijn AM, Prokocimer M. Thiamine deficiency in patients with B-chronic lymphocytic leukaemia: a pilot study. Postgrad Med J. 2001 ; 77 (911). 582-585
125. Greenspon J, Perrone EE, Alaish SM. Shoshin beriberi mimicking central line sepsis in a child with short bowel syndrome. World J Pediatr. 2010 ; 6 (4). 366-368
126. Falder S, Silla R, Phillips M, et al. Thiamine supplementation increases serum thiamine and reduces pyruvate and lactate levels in burn patients. Burns. 2010 ; 36 (2). 261-269
127. Brown RO, Compher C. American Society for Parenteral and Enteral Nutrition Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure. JPEN J Parenter Enteral Nutr. 2010 ; 34 (4). 366-377
128. Bellomo R, Ronco C, Kellum JA, et al. ADQI workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 ; 8: R204 - R212
129. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multi-center study. JAMA. 2005 ; 294: 313-318
130. Ympa YP, Sakr Y, Reinhart K, Vincent JL. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med. 2005 ; 118: 827-832
131. Chertow GW, Soroko SH, Paganini EP, et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 2006 ; 70: 1120-1126
132. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. http://www2.kidney.org/professionals/KDOQI/guidelines-ckd/toc.htm. Accessed October 6, 2014.
133. Cano NJ, Aparicio M, Brunori G, et al. ESPEN. ESPEN guidelines on parenteral nutrition: adult renal failure. Clin Nutr. 2009 ; 28 (4). 401-414
134. Rizzo MA, Frediani F, Granata A, Ravasi B, Cusi D, Gallieni M. Neurological complications of hemodialysis: state of the art. J Nephrol. 2012 ; 25 (02). 170-182
135. Berger MM, Shenkin A, Revelly JP, et al. Copper, selenium, zinc and thiamine, balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr. 2004 ; 80: 410-416
136. Locatelli F, Fouque D, Heimburger O, et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant. 2002 ; 17: 563-572
137. Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001 ; 38 (5). 941-947
138. van Dongen S, Brown RM, Brown GK, Thorburn DR, Boneh A. Thiamine-responsive and non-responsive patients with PDHC-E1 deficiency: a retrospective assessment. [published ahead of print April 10, 2014]. JIMD Rep.
139. Oishi K, Diaz GA. Thiamine-responsive megaloblastic anemia syndrome. GeneReviews®. Seattle, WA: University of Washington. Initial posting: October 24, 2003. Last update: September 20, 2012. Accessed August 23, 2014
140. Angelousi A, Larger E. Anaemia, a common but often unrecognized risk in diabetic patients: a review. Diabetes Metab. 2014;pii: S1262-3636(14)00109-8.
141. Pácal L, Kuricová K, Kaňková K. Evidence for altered thiamine metabolism in diabetes: is there a potential to oppose gluco- and lipotoxicity by rational supplementation?. World J Diabetes. 2014 ; 5 (3). 288-295